Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Clinical trial NCT01774578 · TERMINATED

Trial details

NCT number: NCT01774578
Sponsor: NewLink Genetics Corporation
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Progression of Non-small Cell Lung Cancer Non-small Cell Lung Cancer Recurrent

Start date: 2013-02-01
Primary completion: 2016-05-18
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.